134 related articles for article (PubMed ID: 31255483)
1. Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials.
Berger O; Ortial S; Wein S; Denoyelle S; Bressolle F; Durand T; Escale R; Vial HJ; Vo-Hoang Y
Bioorg Med Chem Lett; 2019 Aug; 29(16):2203-2207. PubMed ID: 31255483
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.
Degardin M; Wein S; Gouni S; Tran Van Ba C; Duckert JF; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2012 Jun; 7(6):991-1001. PubMed ID: 22544438
[TBL] [Abstract][Full Text] [Related]
3. Development of the first oral bioprecursors of bis-alkylguanidine antimalarial drugs.
Degardin M; Wein S; Duckert JF; Maynadier M; Guy A; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2014 Feb; 9(2):300-4. PubMed ID: 24403182
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of amidoxime derivatives for orally potent C-alkylamidine-based antimalarial agents.
Ouattara M; Wein S; Denoyelle S; Ortial S; Durand T; Escale R; Vial H; Vo-Hoang Y
Bioorg Med Chem Lett; 2009 Feb; 19(3):624-6. PubMed ID: 19124242
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors.
Margout D; Gattacceca F; Moarbess G; Wein S; Tran van Ba C; Le Pape S; Berger O; Escale R; Vial HJ; Bressolle FM
Eur J Pharm Sci; 2011 Jan; 42(1-2):81-90. PubMed ID: 21050886
[TBL] [Abstract][Full Text] [Related]
6. N-substituted bis-C-alkyloxadiazolones as dual effectors: efficient intermediates to amidoximes or amidines and prodrug candidates of potent antimalarials.
Degardin M; Wein S; Durand T; Escale R; Vial H; Vo-Hoang Y
Bioorg Med Chem Lett; 2009 Sep; 19(17):5233-6. PubMed ID: 19643611
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimalarial activity of new 1,12-bis(N,N'-acetamidinyl)dodecane derivatives.
Ouattara M; Wein S; Calas M; Hoang YV; Vial H; Escale R
Bioorg Med Chem Lett; 2007 Feb; 17(3):593-6. PubMed ID: 17123818
[TBL] [Abstract][Full Text] [Related]
8. Reverse-benzamidine antimalarial agents: design, synthesis, and biological evaluation.
Berger O; Wein S; Duckert JF; Maynadier M; El Fangour S; Escale R; Durand T; Vial H; Vo-Hoang Y
Bioorg Med Chem Lett; 2010 Oct; 20(19):5815-7. PubMed ID: 20800484
[TBL] [Abstract][Full Text] [Related]
9. Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities.
Caldarelli SA; Hamel M; Duckert JF; Ouattara M; Calas M; Maynadier M; Wein S; Périgaud C; Pellet A; Vial HJ; Peyrottes S
J Med Chem; 2012 May; 55(10):4619-28. PubMed ID: 22591034
[TBL] [Abstract][Full Text] [Related]
10. Mono- and bis-thiazolium salts have potent antimalarial activity.
Hamzé A; Rubi E; Arnal P; Boisbrun M; Carcel C; Salom-Roig X; Maynadier M; Wein S; Vial H; Calas M
J Med Chem; 2005 May; 48(10):3639-43. PubMed ID: 15887971
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.
Nicolas O; Margout D; Taudon N; Wein S; Calas M; Vial HJ; Bressolle FM
Antimicrob Agents Chemother; 2005 Sep; 49(9):3631-9. PubMed ID: 16127032
[TBL] [Abstract][Full Text] [Related]
12. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
13. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
[TBL] [Abstract][Full Text] [Related]
14. Dual molecules as new antimalarials.
Salom-Roig XJ; Hamzé A; Calas M; Vial HJ
Comb Chem High Throughput Screen; 2005 Feb; 8(1):49-62. PubMed ID: 15720197
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activities of a diverse set of triazole-containing furamidine analogues.
Berger O; Kaniti A; van Ba CT; Vial H; Ward SA; Biagini GA; Bray PG; O'Neill PM
ChemMedChem; 2011 Nov; 6(11):2094-108. PubMed ID: 21905228
[TBL] [Abstract][Full Text] [Related]
16. Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.
Hall JE; Kerrigan JE; Ramachandran K; Bender BC; Stanko JP; Jones SK; Patrick DA; Tidwell RR
Antimicrob Agents Chemother; 1998 Mar; 42(3):666-74. PubMed ID: 9517949
[TBL] [Abstract][Full Text] [Related]
17. Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.
Caldarelli SA; Boisbrun M; Alarcon K; Hamzé A; Ouattara M; Salom-Roig X; Maynadier M; Wein S; Peyrottes S; Pellet A; Calas M; Vial H
Bioorg Med Chem Lett; 2010 Jul; 20(13):3953-6. PubMed ID: 20605450
[TBL] [Abstract][Full Text] [Related]
18. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Werbovetz K
Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
[TBL] [Abstract][Full Text] [Related]
19. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
Faísca Phillips AM; Nogueira F; Murtinheira F; Barros MT
Bioorg Med Chem Lett; 2015; 25(10):2112-6. PubMed ID: 25881827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
